Shareholding disclosure

Polar Capital LLP

Declared position

2.96%

Threshold

Crossed upwards

Timeline

Published

18.07.2019

Transaction

11.07.2019

Voting rights breakdown

Voting rights acquired2.96%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAJ7F000A3

Beneficial owner

Polar Capital LLP

Declared address

Polar Capital LLP, SW1E5JD/ London

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Polar Capital LLP

Newron Pharmaceuticals S.p.A.18.07.2019TAJ7F000A3

Disclosure summary

Polar Capital LLP disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 18.07.2019, at 2.96% of voting rights. Notice category: Single shareholder.

Disclosed position

2.96%

Voting rights acquired

Voting rights acquired2.96%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Polar Capital LLP disclosed a holding in Newron Pharmaceuticals S.p.A., published on 18.07.2019.

Publication date18.07.2019

Transaction date11.07.2019

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerPolar Capital LLP

Declared addressPolar Capital LLP, SW1E5JD/ London

CategorySingle shareholder

Voting rights acquired2.96%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAJ7F000A3

Source: SIX Exchange Regulation · Publication date: 18.07.2019

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open